SPRY Latest Quarter’s Earnings
Announce Date8/13/2026
EPS Actual (USD)-0.63
Revenue Actual (USD)33.66M
ARS Pharmaceuticals Inc Earnings Dates & Reports
This page offers detailed ARS Pharmaceuticals Inc earnings data including the latest ARS Pharmaceuticals Inc earnings report, the upcoming ARS Pharmaceuticals Inc earnings date, historical data and ARS Pharmaceuticals Inc earnings call news.
SPRY Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
SPRY FY2025 Earnings
EPS (YoY)-1.74-2206.28%
Revenue (YoY)84.28M-5.46%
ARS Pharmaceuticals Inc (SPRY) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 8/13/2026 | 06/2026 | -0.63/-0.49 | 33.66M/31.32M | -27.45% | 7.46% |
| 5/15/2026 | 03/2026 | -0.61/-0.53 | 22.68M/22.23M | -16.17% | 2.03% |
| 3/9/2026 | 12/2025 | -0.42/-0.44 | 28.09M/25.58M | 5.52% | 9.79% |
| 11/10/2025 | 09/2025 | -0.52/-0.47 | 32.50M/28.95M | -9.68% | 12.26% |
| 8/13/2025 | 06/2025 | -0.46/-0.47 | 15.72M/13.78M | 2.91% | 14.09% |
| 5/14/2025 | 03/2025 | -0.35/-0.35 | 7.97M/7.48M | 0.16% | 6.57% |
| 3/20/2025 | 12/2024 | 0.51/-0.14 | 86.58M/15.82M | 466.20% | 447.36% |
| 11/13/2024 | 09/2024 | -0.20/-0.15 | 2.07M/575.00K | -33.65% | 259.65% |
ARS Pharmaceuticals Inc Latest Earnings Call Transcripts
ARS Pharmaceuticals (SPRY) Q2 2026 Earnings Call: neffy Share Gains and Cost Reset
ARS Pharmaceuticals Q2 2026 earnings call: revenue reached $33.7 million as neffy gained share, while management cut costs and targeted 2027 cash break-even.